01 2Aspen Pharmacare Holdings
02 1Cohance Lifesciences
03 4Alfred E Tiefenbacher GmbH
04 2ANGITA PHARMA INC.
05 3Actavis Inc
06 2Adcock Ingram
07 5Alembic Pharmaceuticals Limited
08 4Alphapharm PTY Ltd
09 2Anchen Pharmaceutical, Inc
10 6Apotex Inc
11 4Arrow Pharmaceuticals
12 2Ascent Innovative Medicines
13 2Aspire Lifesciences Pvt Ltd
14 2Cipla Medpro South Africa
15 2Eurofarma Laboratorios S.A
16 4Generic Health
17 3Hikma Pharmaceuticals
18 2INNOVATA PHARMACEUTICALS
19 2JAMP PHARMA
20 1Jivita Health Care
21 2LABORATORIOS NORMON SA
22 3Lupin Ltd
23 2MEDICAP LABS
24 2Macleods Pharmaceuticals Limited
25 2Neuraxpharm
26 2Osmotica Pharmaceuticals
27 2PHARMOBEDIENT
28 2PRO DOC LIMITEE
29 4Pfizer Consumer Healthcare
30 11Pfizer Inc
31 2Pharma Dynamics
32 2Precise Group
33 3Rubicon Research
34 2SANIS HEALTH INC
35 2SIVEM PHARMACEUTICALS ULC
36 10Sandoz B2B
37 2Taro Pharmaceutical Industries
38 2Teva Pharmaceutical Industries
39 4WAGNER PHARMACEUTICALS PTY LTD
40 5Yichang Humanwell Pharmaceutical
41 3Zydus Pharmaceuticals
42 2Blank
01 4Coated Tablet
02 3ER Tablet
03 2Extended Release Tablet
04 6Extended-Release Tablet
05 2FCT
06 2Granules
07 2Modified Release Tablet
08 4Prolonged Release tablet
09 1Sustain Release Pellet
10 10TAB
11 20TABLET (EXTENDED-RELEASE)
12 36TABLET, EXTENDED RELEASE;ORAL
13 2Tablet
14 32Blank
01 2Allowed
02 4Authorized
03 2Cancelled
04 4DISCN
05 4EU Dossier Readiness-Q1 2020
06 12Generic
07 2Originator
08 20Prescription
09 30RX
10 46Blank
01 2AG-DESVENLAFAXINE
02 2APO-DESVENLAFAXINE
03 4APO-Desvenlafaxine MR
04 4BTC Desvenlafaxine
05 4DESVEN
06 10DESVENLAFAXINE
07 27DESVENLAFAXINE SUCCINATE
08 4DESVENLAFAXINE-WGR XR
09 1Depven 100 XL
10 1Depven 50 XL
11 4Desfax
12 2Deslafeks
13 1Deslafore XR 100
14 1Deslafore XR 50
15 2Desveneurax
16 4Desvenlafaxine GH XR
17 4Desvenlafaxine Sandoz
18 2Desvenlafazine Normon
19 2Enzude
20 1Exlov XR 100 mg
21 1Exlov XR 50 mg
22 1Exsira 100mg
23 1Exsira 50mg
24 2JAMP DESVENLAFAXINE
25 2KHEDEZLA
26 5PRISTIQ
27 6Pristiq
28 2SANDOZ DESVENLAFAXINE
29 2TARO-DESVENLAFAXINE
30 2TEVA-DESVENLAFAXINE
31 1Voloxin 100mg
32 1Voloxin 50mg
33 18Blank
01 32Australia
02 4Brazil
03 20Canada
04 2China
05 4Germany
06 8India
07 12South Africa
08 6Spain
09 2Switzerland
10 36USA
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Voloxin 50mg
Dosage Form : TAB
Dosage Strength : 50mg
Packaging : 28X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Sustain Release Pellet
Dosage Strength : 41.38%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Prolonged Release tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Voloxin 100mg
Dosage Form : TAB
Dosage Strength : 100mg
Packaging : 28X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Prolonged Release tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Prolonged Release tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Prolonged Release tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204003
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204003
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2018-09-14
Application Number : 204003
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DESVENLAFAXINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 204009
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DESVENLAFAXINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 204009
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PRISTIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2008-02-29
Application Number : 21992
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PRISTIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2008-02-29
Application Number : 21992
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PRISTIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2014-08-20
Application Number : 21992
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204028
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204028
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2017-10-11
Application Number : 204020
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2017-10-11
Application Number : 204020
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2022-11-30
Application Number : 204020
Regulatory Info : RX
Registration Country : USA
